RxDoctor Payments Data

Gary Smith, MD

Family Medicine · Nashville, TNNPI 1659375228

Payments from drug & device makers

$8,213in general payments, 2019–2025

Across 448 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$1K
  • Pfizer$930
  • AstraZeneca$754
  • Lilly USA, LLC$657
  • Amgen$548
  • plus $3K from 41 others

What the payments were for

  • Food & beverage$8,11399%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,213 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$62,269
Medicare patients
311
Services billed
1,138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban108$74,035
FarxigaDapagliflozin Propanediol70$66,699
MounjaroTirzepatide44$48,993
OzempicSemaglutide44$48,947
JanuviaSitagliptin Phosphate38$30,720
XareltoRivaroxaban29$26,726
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$19,628
Synjardy XrEmpagliflozin/Metformin Hcl23$14,079
MyrbetriqMirabegron16$13,749
TradjentaLinagliptin13$8,875
Breo ElliptaFluticasone/Vilanterol20$8,629
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen285$6,351
Candesartan Cilexetil61$5,192
Atorvastatin Calcium340$5,089
Valsartan63$4,098

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$930$74,035108 claims
AstraZenecaFarxiga, Symbicort$754$69,90984 claims
Lilly USA, LLCMounjaro$657$48,99344 claims
Novo NordiskOzempic$229$48,94744 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$53$32,03662 claims
MerckJanuvia$198$30,72038 claims
Johnson & JohnsonXarelto$1,272$26,72629 claims
Boehringer IngelheimSynjardy Xr, Tradjenta$152$22,95436 claims
Astellas Pharma US IncMyrbetriq$141$13,74916 claims
AbbVieSynthroid$1,148$2,87634 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →